Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Capgemini (CAPP.PA)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (€) Price Target (€) Rating
2022-02-28188.30226.00Buy
2022-04-29196.10235.00Buy
2022-07-29185.35217.00Buy
2023-02-24175.95208.00Buy
2023-05-05167.45203.00Buy
2023-07-31164.85200.00Buy
2023-11-08171.60197.00Buy
2024-01-10182.45209.00Buy
2024-02-22221.50235.00Neutral
2024-08-02179.35225.00Buy
2024-10-31159.20210.00Buy
2025-02-20159.90220.00Buy
2025-05-02142.55173.00Buy

Disclosures

  • An employee of UBS is an officer, director, or advisory board member of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.